4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
TED · 307755-2026Award noticeawardedNo deadline given
Value
Estimated€2,434,682 · 2,434,682.33 EUR
Awarded€153,210 · 153,210.2 EUR
WinnerBIOGEN SPAIN S.L.
Who already wins at this buyer
Firms with recorded awards from Hospital Clinico San Carlos in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| BIOGEN SPAIN S.L. | 1 | €153,210 | 2026-05-28 |
| LABORATORIO ABBVIE, S.L.U | 1 | €85,172 | 2026-06-25 |
Full buyer profile: what Hospital Clinico San Carlos buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Similar tenders
Closest by meaning — across languages, via embeddings.